Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

• Main Authors: Verma, Akash, Chopra, Akhil, Lee, Yeo W., Bharwani, Lavina D., Asmat, Atasha B., Aneez, Dokeu B. A., Akbar, Fazuludeen A., Lim, Albert Y. H., Chotirmall, Sanjay Haresh, Abisheganaden, John
• Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
• Format: Article
• Language: English
• Published: 2017
• Subjects: Lung cancer; Adenocarcinoma
• Online Access: https://hdl.handle.net/10356/81823; http://hdl.handle.net/10220/42274
• Institution: Nanyang Technological University

Background and Objective: Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) are effective against lung adenocarcinoma. However, limited data is available assessing the effectiveness of EGFR-TKI use in preventing re-accumulation of MPE. To our knowledge, there is no literature o...